Add Company
Join Now

Yaupon Therapeutics Revenue and Competitors

License our Company Data API

Radnor, Pa USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Yaupon Therapeutics's estimated annual revenue is currently $1.7M per year.(i)
  • Yaupon Therapeutics's estimated revenue per employee is $213,125

Employee Data

  • Yaupon Therapeutics has 8 Employees.(i)
  • Yaupon Therapeutics grew their employee count by -11% last year.

Yaupon Therapeutics's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.6M7-12%N/AN/A
#2
$4M3881%N/AN/A
#3
N/A7627%N/AN/A
#4
$0.9M50%N/AN/A
#5
$1.1M833%N/AN/A
#6
$10.9M617%N/AN/A
#7
$0.7M929%N/AN/A
#8
$4M20-5%N/AN/A
#9
$1.7M1122%N/AN/A
#10
$7.6M492%N/AN/A
Add Company

What Is Yaupon Therapeutics?

Yaupon Therapeutics is a privately-held specialty pharmaceutical company that develops small molecule pharmaceuticals licensed from under-served academic laboratories. The Company’s lead product candidate, Clearazide™, a proprietary topical formulation of nitrogen mustard (NM), is being evaluated in a pivotal Phase II/III trial under a Special Protocol Assessment (SPA) with the FDA for the treatment of early-stage cutaneous T-cell lymphoma – mycosis fungoides (CTCL-MF). The FDA has granted Clearazide™ fast-track designation and orphan drug status.

keywords:N/A

N/A

Total Funding

8

Number of Employees

$1.7M

Revenue (est)

-11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.5M90%N/A
#2
$1.3M129%N/A
#3
$2.5M148%N/A
#4
$2.4M16-30%N/A
#5
$1.6M22-31%$17.2M